Correction

Authors

  • Gerd Meyer zu Horste MD,

    1. Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, University of Göttingen, Göttingen, Germany
    Search for more papers by this author
    • G.M.z.H. and T.P. contributed equally to this article.

  • Thomas Prukop,

    1. Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, University of Göttingen, Göttingen, Germany
    Search for more papers by this author
    • G.M.z.H. and T.P. contributed equally to this article.

  • David Liebetanz MD,

    1. Department of Clinical Neurophysiology, University of Göttingen, Göttingen, Germany
    Search for more papers by this author
  • Wiebke Mobius PhD,

    1. Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, University of Göttingen, Göttingen, Germany
    Search for more papers by this author
  • Klaus-Armin Nave PhD,

    1. Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, University of Göttingen, Göttingen, Germany
    Search for more papers by this author
  • Michael W. Sereda MD

    Corresponding author
    1. Department of Neurogenetics, Max-Planck-Institute of Experimental Medicine, University of Göttingen, Göttingen, Germany
    2. Center of Neurology, University of Göttingen, Göttingen, Germany
    • Max-Planck-Institute of Experimental Medicine, Department of Neurogenetics, Hermann-Rein-Strasse 3, D-37075 Göttingen, Germany
    Search for more papers by this author

Abstract

In the original published article, the first sentence of the Intrepretation section in the article's abstract was incorrectly printed. The sentence should read: Intrepretation:Progesterone-antagonist long-term therapy reduces Pmp22 overexpression to a degree at which the axonal support function of Schwann cells is better maintained than myelination.

Ancillary